Spencer Knight

All Posts

  • This Big Cat Won’t Catch This Deere

    By Spencer Knight - February 13, 2013 | Tickers: AGCO, CAT, DE

    Deere  (NYSE: DE) reported solid first quarter earnings on Feb. 27 -- well, at least until a discussion about corn and soybean prices came about.  Nevertheless, the company's strong performanceindicates that the current state of the machinery and agricultural market is stabilizing and growing. 

    AGCO (NYSE: AGCO) supports this claim as the firm’s year end results were also strong.  The discussion regarding lower corn and soybean prices is simply more »

  • This Is Just The Beginning

    By Spencer Knight - January 25, 2013 | Tickers: T, GE, VZ

    Pensions, like Social Security, are fantastic ideas at the outset, but years of stimulus, changing regulations, and overzealous discount rates and assumed rates of return have ruined many pensions.  SS is a different story that has more to do with the Baby Boomer generation being about as large as the two subsequent generations combined, but the point is that guaranteeing employees or persons a specific retirement package throughout retirement is more »

  • Following A Plan Doesn't Matter Anymore

    By Spencer Knight - December 14, 2012 | Tickers: AMRN, DNDN, REGN

    There has been quite the fuss over Amarin (NASDAQ: AMRN) lately.  Investors have been hoping for the fish-oil drug maker to be bought out by a larger firm or, at the very least, receive some sort of marketing agreement for the firm’s only FDA approved drug, Vascepa.  Because of the lack of any material deal the stock has been a cliff jumper since its approval in late July.

    More more »

  • How to Build a House of Stocks

    By Spencer Knight - December 12, 2012 | Tickers: HOV, LEN, PHM, TOL | Editor's Choice

    Less than a decade ago far too many individuals purchased homes – or more realistically rented homes from the bank – as if they were objects and this in part caused the housing bubble that triggered the worst recession we have ever seen.  Subsequently, home prices declined anywhere from 30%-60%.

    Fortunately investors that take advantage of home building stocks before the train leaves the station will be rewarded over the next more »

  • Will This Hated Sector Continue to Shine?

    By Spencer Knight - November 29, 2012 | Tickers: BAC, C, FB, GS, JPM, MET, NES.DL, PRI, USB, WFC

    As 2012 winds down we would like to review some of the most hated financial stocks and determine which performed the best and which have the highest probability of flourishing in 2013.  The problem with the financial sector is that the media and federal regulations (think Volcker Rule, if it ever goes into effect) have made many financial firms appear to be the worst thing ever created, and this is more »

  • The Apple Seeds Have Been Planted

    By Spencer Knight - November 26, 2012 | Tickers: AAPL, BBY, MSFT, TGT, WMT

    Now that Apple's (NASDAQ: AAPL) stock has made a clear short term turn it is important to point out why the Apple seeds have been planted for a Spring harvest.  This has lot to do with Wal-mart (NYSE: WMT), Target (NYSE: TGT), and Best Buy (NYSE: BBY).  As many people know, one of Wal-mart's advertised Black Friday specials is the iPad 2 for $399 along with a $75 more »

  • Great News: The Selling is Over

    By Spencer Knight - November 21, 2012 | Tickers: BAC, F, GM, DIA

    After a bitter bout of selling for superficial reasons, we are expecting to see the market make a full recovery over the next three to four months.  From the early October 2012 high, the Dow Jones Industrial Average (NYSEMKT: DIA) slipped about 8.2%.  Many put the blame on the Presidential election for this slide, and many more predicted the market would completely and utterly collapse after a President Obama more »

  • Large-Cap Biotechs: Who Ya Got?

    By Spencer Knight - August 13, 2012 | Tickers: GILD, GSK, MRK, REGN

    While many biotech traders focus on simply trading, or gambling, on micro or small-cap biotech stocks there are several large-cap biotechs that are well worth a long term investment. Three biotech firms with an outstanding medium term (1-5 years) outlook are Regeneron (NASDAQ: REGN), Gilead (NASDAQ: GILD), and Amgen. Of these three, Gilead has the best short term potential and investors that realize this early will be rewarded very nicely more »

  • Big Data Will Lead to Big Profits

    By Spencer Knight - August 12, 2012 | Tickers: EMC, FB, FIO, NTAP, CRM, VMW

    Over the past several years the "Big Data" revolution has been boiling, but the true financial potential has yet to be released. Big data, and subsequently cloud storage, is simply the process of storing large data sets in and on an easily accessible source so that one can retrieve and organize that particular data. One of the simplest examples of this is your email or any social media outlet. The more »

  • Alcoa is the Dow's Best Value Play

    By Spencer Knight - July 31, 2012 | Tickers: AA, BAC, F, HPQ

    Alcoa (NYSE: AA) is an aluminum miner, manufacturer, and producer that, for lack of a better phrase, has been one of the worst blue chips since July of 2011. There are several reasons for Alcoa's year-long slide. The spark for this trend came from last summer's European and American debt issues that threatened to derail the modern economic cycle -- at least that is what bears wanted investors to more »

  • Skechers Has Plenty of Gorun In The Tank

    By Spencer Knight - July 26, 2012 | Tickers: NKE, SKX

    Skechers (NYSE: SKX) produced impressive second quarter earnings after the close on Wednesday, July 25th. No there was not a huge profit, or any profit at all, but a trend of cutting costs and improving income make the stock very attractive at this point. Not to mention Skechers is down about 45% over the past two years. Because of this some say Skechers is a falling knife. On the other more »